Literature DB >> 36211809

PDIA3 as a potential bridge between immunogenic cell death and autoreactivity.

Jonathan G Pol1,2, Céleste Plantureux3, María Pérez-Lanzón1,2, Guido Kroemer4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 36211809      PMCID： PMC9542941          DOI： 10.1080/2162402X.2022.2130558

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN： 2162-4011            Impact factor:   7.723


× No keyword cloud information.
  10 in total

1.  Hallmarks of health.

Authors:  Carlos López-Otín; Guido Kroemer
Journal:  Cell       Date:  2021-04-01       Impact factor: 41.582

Review 2.  Immunogenic cell stress and death.

Authors:  Guido Kroemer; Lorenzo Galluzzi; Claudia Galassi; Laurence Zitvogel
Journal:  Nat Immunol       Date:  2022-02-10       Impact factor: 25.606

3.  PDIA3 epitope-driven immune autoreactivity contributes to hepatic damage in type 2 diabetes.

Authors:  Cristina C Clement; Jaspreet Osan; Aitziber Buque; Padma P Nanaware; Yoke-Chen Chang; Giorgio Perino; Madhur Shetty; Takahiro Yamazaki; Wanxia Li Tsai; Aleksandra M Urbanska; J Mauricio Calvo-Calle; Shakti Ramsamooj; Shakti Ramsamooj; Diego Vergani; Giorgina Mieli-Vergani; Benedetta Terziroli Beretta-Piccoli; Massimo Gadina; Cristina Montagna; Marcus DaSilva Goncalves; Federica Sallusto; Lorenzo Galluzzi; Rajesh K Soni; Lawrence J Stern; Laura Santambrogio
Journal:  Sci Immunol       Date:  2022-08-19

4.  Protein disulfide isomerase A3-specific Th1 effector cells infiltrate colon cancer tissue of patients with circulating anti-protein disulfide isomerase A3 autoantibodies.

Authors:  Cristiana Caorsi; Elena Niccolai; Michela Capello; Rosario Vallone; Michelle S Chattaragada; Brunilda Alushi; Anna Castiglione; Gianni Ciccone; Alessandro Mautino; Paola Cassoni; Lucia De Monte; Sheila M Álvarez-Fernández; Amedeo Amedei; Massimo Alessio; Francesco Novelli
Journal:  Transl Res       Date:  2015-12-23       Impact factor: 7.012

5.  The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death.

Authors:  T Panaretakis; N Joza; N Modjtahedi; A Tesniere; I Vitale; M Durchschlag; G M Fimia; O Kepp; M Piacentini; K-U Froehlich; P van Endert; L Zitvogel; F Madeo; G Kroemer
Journal:  Cell Death Differ       Date:  2008-05-09       Impact factor: 15.828

6.  Immunosuppression by Mutated Calreticulin Released from Malignant Cells.

Authors:  Peng Liu; Liwei Zhao; Friedemann Loos; Caroline Marty; Wei Xie; Isabelle Martins; Sylvie Lachkar; Bo Qu; Emmanuelle Waeckel-Énée; Isabelle Plo; William Vainchenker; Franck Perez; David Rodriguez; Carlos López-Otin; Peter van Endert; Laurence Zitvogel; Oliver Kepp; Guido Kroemer
Journal:  Mol Cell       Date:  2019-11-27       Impact factor: 17.970

Review 7.  Beneficial autoimmunity improves cancer prognosis.

Authors:  Laurence Zitvogel; Claude Perreault; Olivera J Finn; Guido Kroemer
Journal:  Nat Rev Clin Oncol       Date:  2021-05-11       Impact factor: 65.011

8.  Integrins and ERp57 Coordinate to Regulate Cell Surface Calreticulin in Immunogenic Cell Death.

Authors:  Chi-Chao Liu; Pascal Leclair; Foujan Pedari; Heidi Vieira; Mahdis Monajemi; Laura M Sly; Gregor S Reid; Chinten James Lim
Journal:  Front Oncol       Date:  2019-05-28       Impact factor: 6.244

9.  Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma.

Authors:  Juliette Paillet; Céleste Plantureux; Sarah Lévesque; Julie Le Naour; Gautier Stoll; Allan Sauvat; Pamela Caudana; Jimena Tosello Boari; Norma Bloy; Sylvie Lachkar; Isabelle Martins; Paule Opolon; Andrea Checcoli; Agathe Delaune; Noémie Robil; Pierre de la Grange; Juliette Hamroune; Franck Letourneur; Gwennhael Autret; Patrick S C Leung; M Eric Gershwin; Jie S Zhu; Mark J Kurth; Bouchra Lekbaby; Jérémy Augustin; Youra Kim; Shashi Gujar; Cédric Coulouarn; Laura Fouassier; Laurence Zitvogel; Eliane Piaggio; Chantal Housset; Patrick Soussan; Maria Chiara Maiuri; Guido Kroemer; Jonathan G Pol
Journal:  J Exp Med       Date:  2021-09-08       Impact factor: 14.307

10.  Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively.

Authors:  Zewei Tu; Qin Ouyang; Xiaoyan Long; Lei Wu; Jingying Li; Xingen Zhu; Kai Huang
Journal:  Front Immunol       Date:  2022-03-25       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.